Cargando…
Involvement and Therapeutic Potential of the GABAergic System in the Fragile X Syndrome
Many drugs have been developed that are able to modulate the GABAergic system, which is involved in anxiety, depression, epilepsy, insomnia, and learning and memory. The recent observation that the GABA(A) receptor is underexpressed in the fragile X syndrome, an inherited mental retardation disorder...
Autores principales: | Heulens, Inge, D'Hulst, Charlotte, Braat, Sien, Rooms, Liesbeth, Kooy, R. Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763973/ https://www.ncbi.nlm.nih.gov/pubmed/21057732 http://dx.doi.org/10.1100/tsw.2010.211 |
Ejemplares similares
-
Metabonomics adds a new dimension to fragile X syndrome
por: Heulens, Inge, et al.
Publicado: (2011) -
Positron Emission Tomography (PET) Quantification of GABA(A) Receptors in the Brain of Fragile X Patients
por: D’Hulst, Charlotte, et al.
Publicado: (2015) -
Targeting fragile X
por: Gantois, Ilse, et al.
Publicado: (2002) -
Modulation of the GABAergic pathway for the treatment of fragile X syndrome
por: Lozano, Reymundo, et al.
Publicado: (2014) -
Mouse models of fragile X-related disorders
por: Willemsen, Rob, et al.
Publicado: (2023)